Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational HighlightsGlobeNewsWire • Thursday
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024GlobeNewsWire • 09/11/24
Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) SubmissionGlobeNewsWire • 09/05/24
Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million EmployeesGlobeNewsWire • 09/03/24
Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024GlobeNewsWire • 08/21/24
Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register NowGlobeNewsWire • 08/20/24
Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key IndustriesGlobeNewsWire • 08/13/24
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) PathwayGlobeNewsWire • 08/01/24
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi ArabiaGlobeNewsWire • 07/24/24
Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study SuccessGlobeNewsWire • 07/18/24
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of ResultsGlobeNewsWire • 06/28/24
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account AcquisitionsGlobeNewsWire • 06/27/24
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening TechnologyGlobeNewsWire • 06/18/24
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening TechnologyGlobeNewsWire • 06/12/24
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024GlobeNewsWire • 06/06/24
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) StudyGlobeNewsWire • 05/29/24
Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective SolutionsGlobeNewsWire • 05/23/24
Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety EventGlobeNewsWire • 05/17/24
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsGlobeNewsWire • 05/08/24
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsGlobeNewsWire • 04/18/24
Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderGlobeNewsWire • 04/11/24
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCGlobeNewsWire • 03/26/24
Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 03/12/24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 03/11/24